GENETIC SIGNATURES LIMITED
ASX:GSSPharmaceuticals, Biotechnology & Life SciencesToday’s holders own 97.7% of what they think they own, once every option and right converts.
No major dilution pressure signals in current disclosures
GENETIC SIGNATURES LIMITED's ordinary share count increased by 0.1% between September 2024 and December 2024, its latest share-count filing, reaching 227M shares. The company had no capital raises in the past 24 months. Options and rights on issue could convert into 5M new shares, equal to 2.4% of the current share count, with none in the money and the nearest expiry in November 2035. The company has more than 4 quarters of funding at the recent spend rate. No proposed securities issues (Appendix 3B) are pending.
Quick answers · 4
How much placement capacity does GSS have left?
None of the 15% placement capacity counted as used in the last 12 months (estimate). Under ASX Listing Rule 7.1 a company may place up to 15% of its shares in 12 months without shareholder approval.
How much cash does GSS have?
In its quarterly cash report for the quarter ended 30 Sept 2026, Genetic Signatures reported $20.9M of cash and estimated 21.3 quarters of funding available at its current rate of spending. That is the company's own estimate.
When do GSS's options expire?
Unexercised options and rights equal 2.4% of Genetic Signatures's shares on issue; the nearest expiry is Nov 2035.
How much has GSS's share count grown?
Genetic Signatures has 227.1M shares on issue as at 28 Oct 2026, up 0.1% over 24 months according to its Appendix 2A filings.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 30 Mar 2026 | 3H · cancellation | GSS : ORDINARY FULLY PAID | 227.1M | Appendix 3H |
| 10 Feb 2026 | 3H · cancellation | GSS : ORDINARY FULLY PAID | 227.1M | Appendix 3H |
| 24 Nov 2025 | 3G · unquoted | GSS : ORDINARY FULLY PAID | 227.1M | Appendix 3G |
| 21 Nov 2025 | 3H · cancellation | GSS : ORDINARY FULLY PAID | 227.1M | Appendix 3H |
| 7 Nov 2025 | 3G · unquoted | GSS : ORDINARY FULLY PAID | 227.1M | Appendix 3G |
Securities on issue over time
Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.
Capital raises
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
- Price-triggered4.6M · 2.0% of sharesOptions and warrants — they convert when the share price clears their exercise price.At least 4.1M of it states no exercise price — that much cannot be called in or out of the money.
- Condition-triggered834k · 0.4% of sharesPerformance and incentive rights — they convert when a hurdle is met, not at a price, and can lapse to nothing.
Exercise price on record: 479k priced, 5.0M where the filing never states one. A security with no exercise price is never counted in the money — nothing is paid to convert it, so there is no price for it to be above.
Each figure is the filing’s own count of securities, not a share count — a 2A never states what one security converts into.
An exercise price is on record for only 8.8% of this supply, so what is in the money today is not a measurement — the tile above reads “—” for that reason. Of the priced supply, 0 is in the money at $0.079 today. No price up to ten times today’s switches on any more priced supply.
- Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
- 5.0M (91.2% of the supply above) states no exercise price at all. It cannot be called in or out of the money at any price, which is why it is hatched rather than plotted.
- 479k more carries an exercise price above ten times today’s — off the right of this axis, and in every total on this page.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| GSSAC | Options | Price-triggered | $0.98 | 11 Nov 2035 | 479k | Filing |
| GSSAG | Performance rights | Condition-triggered | — | — | 334k | Filing Meeting |
| GSSAH | Rights | Condition-triggered | — | — | 500k | Filing Meeting |
| GSSAB | Options | Price-triggered, no exercise price stated | — | — | 4.1M | Filing |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column. For what expires soon across other listed companies, see the options expiry calendar.
A condition-triggered class has no exercise price and usually no expiry: what it vests on is set by a shareholder resolution, not by the register. Where the company lodged a notice of meeting before the class first appears here, it is linked as “Meeting” — that is where terms of this kind are put to shareholders. It is not confirmation that the document sets this class’s conditions, and no link appears where there is no such filing.
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 24 Nov 2025 | Anne Lockwood | Other | 250k | — | — | — | 3Y notice |
| 24 Nov 2025 | Dr Jenny Harry | Other | 250k | — | — | — | 3Y notice |
| 6 Dec 2024 | Dr Neil Gunn | Other | — | 500k | — | — | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.